Group One Trading’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
30,200
-35,600
-54% -$1.31M ﹤0.01% 2570
2025
Q4
$2.34M Buy
65,800
+54,100
+462% +$1.52M ﹤0.01% 2147
2025
Q3
$168K Buy
11,700
+10,700
+1,070% +$127K ﹤0.01% 4862
2025
Q2
$7.18K Buy
1,000
+500
+100% +$2.77K ﹤0.01% 6913
2025
Q1
$3K Hold
500
﹤0.01% 6851
2024
Q4
$3.9K Hold
500
﹤0.01% 6514
2024
Q3
$5.4K Sell
500
-30,400
-98% -$296K ﹤0.01% 5849
2024
Q2
$260K Buy
30,900
+13,200
+75% +$100K ﹤0.01% 3173
2024
Q1
$119K Sell
17,700
-85,200
-83% -$527K ﹤0.01% 4013
2023
Q4
$605K Buy
102,900
+51,600
+101% +$395K ﹤0.01% 2912
2023
Q3
$500K Buy
51,300
+48,500
+1,732% +$575K ﹤0.01% 2910
2023
Q2
$33.2K Buy
+2,800
New +$32.1K ﹤0.01% 5598
2023
Q1
Sell
-1,100
Closed -$12.7K 7304
2022
Q4
$12.7K Buy
1,100
+100
+10% +$1.24K ﹤0.01% 5899
2022
Q3
$15K Sell
1,000
-3,900
-80% -$53.5K ﹤0.01% 6248
2022
Q2
$44K Buy
+4,900
New +$33.4K ﹤0.01% 5670

Other funds holding COGT

Group One Trading's COGT Position: Q4 2025 in Review

Group One Trading sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 50,505 shares — an estimated $1.42M sold.

Group One Trading first reported a position in COGT in Q2 2022 and held it in 10 quarters. The position peaked at $725K in Q3 2025. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Group One Trading reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 50,505 Cogent Biosciences shares in Q4 2025, an estimated $1.42M.
  • Group One Trading first reported a position in Cogent Biosciences in Q2 2022 and held it in 10 quarters.
  • Group One Trading's Cogent Biosciences position peaked at $725K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.